Last reviewed · How we verify

NCT03970408

Median Nerve Excursion During Neurodynamic Mobilization

Completed Last updated 28 July 2021
What this trial tests

trial testing MNT1 in CTS in 18 participants. Completed in 1 December 2020.

Timeline
1 May 2019
Primary endpoint
1 September 2020
1 December 2020

Quick facts

Lead sponsorAliaa Rehan Youssef
StatusCompleted
Study typeOBSERVATIONAL
Enrollment18
Start date1 May 2019
Primary completion1 September 2020
Estimated completion1 December 2020
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Aliaa Rehan Youssef

Who can join

Adults 30 to 50, any sex, with CTS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare changes in longitudinal median nerve excursion when neck flexion and ipsilateral rotation are added to the standard Median neurodynamic test1 (MNT1) position in patients with carpal tunnel syndrome (CTS) and normal controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for CTS

Currently open trials in the same condition.

Other Aliaa Rehan Youssef trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03970408.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing